Table 1.
Autoimmune assessment in case reported.
| Parameter | Patient value | Reference value |
|---|---|---|
| Anti-TPO (CSF) | 11.96 | 0–5.61 UI/ML |
| Anti-dsDNA/ANA | Negative | Negative |
| Anti-SM and anti-Ro/SSA | Negative | Negative |
| cANCA | 1.12 U/mL | 0.00–5.00 |
| Anti-NMDA | Negative | Negative |
| RF | 3.70 | <15 UI/mL |
| IgE | 333 | 0.00–100 mg/dL |
| IgA | 1607 | 70–400 mg/dL |
| IgM | 340 | 40–240 mg/dL |
| CPK | 45 | 26–170 U/L |
Anti-TPO: thyroid peroxidase antibodies; CSF: cerebrospinal fluid; anti-DNA: anti-DNA double strand; ANA: antinuclear autoantibodies; anti-SM: anti-Smith; anti-RO/SSA: anti-Sjögren-syndrome-related antigen A; cANCA: cytoplasmic antineutrophil antibodies; anti-NMDA: anti-N-methyl D-aspartate receptor antibodies; RF: rheumatoid factor; Ig: immunoglobulin; CPK: creatine phosphokinase. Except for anti-TPO, all autoantibodies were performed in patient's serum.